BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang JD, Leise MD. Damned if you do, damned if you don't: The evolving story of de novo and recurrent hepatocellular carcinoma amongst those treated with direct-acting antivirals for hepatitis C virus. Liver Int 2017;37:809-11. [PMID: 28544691 DOI: 10.1111/liv.13422] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Maier S, Donnini D, De Luca L, Avellini C, Sechi LA, Soardo G. Hepatocellular metastasis recurrence in liver transplant after treatment with direct antiviral agents. Clin J Gastroenterol 2020;13:260-6. [PMID: 31410743 DOI: 10.1007/s12328-019-01031-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Rizk NI, Sallam AM, El-Ansary AR, El-Mesallamy HO. HMGB1 and SEPP1 as predictors of hepatocellular carcinoma in patients with viral C hepatitis: Effect of DAAs. Clin Biochem 2019;70:8-13. [PMID: 31158358 DOI: 10.1016/j.clinbiochem.2019.05.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]